Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current ...

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence ...

Although the appendix is generally believed to be a vestigial organ, there is growing evidence pointing to its possible role in modulating gut immunity and microbial homoeostasis.1,2 These roles have ...

Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...

Appendicectomy combined with standard medical therapy is superior to standard medical therapy alone in maintaining remission ...